SEC 13F Intelligence

Managers / Q2 2022 · view latest →

BRIDGER MANAGEMENT, LLC

CIK 0001166309 · 90 PARK AVENUE, 40TH FLOOR, NEW YORK, NY, 10016 · 212-918-0820

Reported Value
$444M
Q2 2022
Positions
43
Filings on Record
37
2019–present window
Filed
Aug 15, 2022
original filing

Summary

Bridger Management, LLC reported $444M in U.S.-listed holdings across 43 positions for Q2 2022.

Its largest position, CHTR, represents 7.2% of the portfolio.

Compared with Q1 2022, the fund opened 7 new positions and exited 16.

Portfolio Metrics

Turnover
+15.3%
vs prior filed quarter
Top-10 Concentration
+54.9%
share of reported value
Largest Position
+7.2%
Charter Communications Inc N
New / Exited
7 / 16
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.3BQ3 ’19: $1.2BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $864MQ2 ’20: $1.1BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $855MQ4 ’21: $773MQ4 ’21Q1 ’22: $610MQ2 ’22: $444MQ3 ’22: $330MQ4 ’22: $247MQ4 ’22Q1 ’23: $268MQ2 ’23: $300MQ3 ’23: $272MQ4 ’23: $260MQ4 ’23Q1 ’24: $222MQ2 ’24: $194MQ3 ’24: $200MQ4 ’24: $186MQ4 ’24Q1 ’25: $201MQ2 ’25: $170MQ3 ’25: $186MQ4 ’25: $156MQ4 ’25Q1 ’26: $128Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 71.3%Other: 20.0%ADR: 8.2%ETP: 0.5%Equity WRT: 0.0%
  • Common Stock · 71.3% · $316M
  • Other · 20.0% · $89M
  • ADR · 8.2% · $36M
  • ETP · 0.5% · $2M
  • Equity WRT · 0.0% · $89,000

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
AZNNASTRAZENECA PLCNEW+376.6K376.6K+$25M$25M
BMRNBIOMARIN PHARMACEUTICAL INCNEW+207.8K207.8K+$17M$17M
HUMHUMANA INCNEW+35.0K35.0K+$16M$16M
PODDINSULET CORPNEW+41.0K41.0K+$9M$9M
R1 RCM INCNEW+186.0K186.0K+$4M$4M
XENEXENON PHARMACEUTICALS INCNEW+77.4K77.4K+$2M$2M
VRDNVIRIDIAN THERAPEUTICS INCNEW+66.3K66.3K+$767,000$767,000
ROSTROSS STORES INCSOLD OUT−308.2K0−$28M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

41 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A7.20%$32M68.2K
2GDDYGODADDY INChistory →CL A6.99%$31M446.0K
3CNCCENTENE CORP DELhistory →COM6.07%$27M318.3K
4DWDMORGAN STANLEYhistory →COM NEW5.87%$26M342.2K
5AZNNASTRAZENECA PLChistory →SPONSORED ADR5.61%$25M376.6K
6CLARIVATE PLCORD SHS5.13%$23M1.64M
7ALCON AGORD SHS4.93%$22M313.1K
8VRTXVERTEX PHARMACEUTICALS INChistory →COM4.64%$21M73.1K
9UBERUBER TECHNOLOGIES INChistory →COM4.58%$20M993.3K
10BMRNBIOMARIN PHARMACEUTICAL INChistory →COM3.88%$17M207.8K
11HUMHUMANA INChistory →COM3.69%$16M35.0K
12CZRCAESARS ENTERTAINMENT INC NEhistory →COM3.55%$16M411.8K
13VRSNVERISIGN INChistory →COM3.54%$16M93.8K
14SKIN2EURTHE BEAUTY HEALTH COMPANYhistory →COM CL A3.17%$14M1.09M
15IRTCIRHYTHM TECHNOLOGIES INChistory →COM2.92%$13M119.8K
16POST HOLDINGS PARTNERING CORUNIT 99/99/99992.75%$12M1.25M
17TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS2.54%$11M1.50M
18IRWDIRONWOOD PHARMACEUTICALS INChistory →COM CL A2.48%$11M956.0K
19AVANTI ACQUISITION CORPUNIT 99/99/99992.25%$10M1.00M
20AIRSAIRSCULPT TECHNOLOGIES INChistory →COM2.19%$10M1.63M
21WILLIAMS ROWLAND ACQUISITIONCOM · *W EXP 12/11/2022.15%$10M1.43M
22PODDINSULET CORPhistory →COM2.01%$9M41.0K
23POSTPOST HLDGS INChistory →COM1.86%$8M100.3K
24FLAME ACQUISITION CORPCOM CL A1.10%$5M500.0K
25RXSTRXSIGHT INChistory →COM1.05%$5M331.4K
26BRBRBELLRING BRANDS INChistory →COMMON STOCK1.05%$5M187.1K
27DCBODOCEBO INCCOM0.97%$4M150.3K
28R1 RCM INCCOM0.88%$4M186.0K
29LIVANOVA PLCSHS0.79%$3M55.9K
30XENEXENON PHARMACEUTICALS INCCOM0.53%$2M77.4K
31QTRXQUANTERIX CORPCOM0.53%$2M144.7K
32MSOSADVISORSHARES TRPURE US CANNABIS0.50%$2M214.1K
33SRZNWSURROZEN INCCL A · *W EXP 08/01/2030.49%$2M1.17M
34ABCAM PLCADS0.46%$2M142.3K
35DMTKQDERMTECH INCCOM0.44%$2M350.8K
36PRVAPRIVIA HEALTH GROUP INCCOM0.29%$1M44.4K
37IMGNEURIMMUNOGEN INCCOM0.28%$1M278.0K
38NAUTNAUTILUS BIOTECHNOLOGY INCCOM0.18%$777,000289.0K
39VRDNVIRIDIAN THERAPEUTICS INCCOM0.17%$767,00066.3K
40NEXI1EURNEXIMMUNE INCCOM0.15%$644,000400.0K
41TECHBIO-TECHNE CORPCOM0.11%$501,0001.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$128M24May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$156M24Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M28Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$170M25Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$201M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$186M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$194M28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$222M31May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$260M28Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$272M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$300M29Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$268M28May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$247M23Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$330M44Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$444M43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$610M52May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$773M44Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$855M46Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B42May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B36Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B35Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$864M36May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B35Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.2B30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B31Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.3B33May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.2B34Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.